Cherry Biotech and Atelerix announce entering in an agreement
Cherry Biotech is delighted to announce the entry into an agreement with Atelerix for the integration
News
Cherry Biotech secures €2.5 million from the European Union for its organ-on-chip technology
Cherry Biotech, a “TechBio” startup specializing in organ-on-chip and organoid technologies for biomedical research, announces its
Cherry Biotech is Coming to Oxford Discovery US 2024 in Boston
Cherry Biotech team is coming to Oxford Discovery US 2024, an event that brings together key
CubiX showed up in Australia
CubiX was presented in Adelaide Thanks to Benjamin Thierry and The South Australian Government Department of
8th Asia-Pacific Worm Meeting 2018
Cherry Biotech will be there with Cherry Temp platform ! The meeting will take place at a convention
Observation Internship (Stage d’observation) at Cherry Biotech
Last week we had the pleasure of receiving Lukas Marcel as an intern at Cherry Biotech
100 years of Insulin
We have looked for ways to make life better for us since the dawn of time.
Cherry Biotech comments on FDA Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control Guidance for Industry
Context What is it? FDA regulations Type 2 Diabetes The purpose of this guidance is to
The Nobel Prize in medicine is about the oxygenation of cells !
A step for the development of the CubiX product line Congratulation to Dr. W. Kaelin, Dr.
Cherry Biotech is at the University of South Australia (Adelaide) to discuss organ on a chip
Cherry Biotech is in Adelaide : Cherry Biotech is at the University of South Australia (Adelaide) until June 22 to discuss and collaborate
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!